title: Selective inhibition of T cell responses by protein and peptide-based immunotherapy.
abstract: Recent progress in understanding antigen presentation to T cells has permitted researchers to identify a number of suitable attack points for selective immunointervention aimed at inhibiting inappropriate T cell activation: major histocompatibility complex (MHC) molecules, T cell receptor (TCR), CD4/CD8, and other accessory molecules. This has fostered the development of a new generation of immunosuppressive agents potentially useful in the prevention and/or treatment of autoimmune diseases, and induction of selective immunosuppression is currently being attempted using monoclonal antibodies or synthetic peptides. The selective immunosuppression by proteins and peptides may be sub-divided into three major categories: i) passive treatments aimed at inhibiting T cell activation by blocking the MHC binding site to any antigenic peptide, including autoantigens; ii) treatments aimed at incapacitating the autoreactive T cells, either by administration of the candidate autoantigen as protein or peptides in tolerogenic form, or by TCR antagonists able to induce selective T cell anergy; and iii) vaccination-like treatments aimed at inducing or enhancing regulatory T cells able to control the activity of pathogenic, autoreactive T cell. It is hoped that some of these approaches may finally lead to effective treatments able to interfere with the induction and/or progression of human autoimmune diseases.
authors.affiliation: Roche Milano Ricerche, Milan, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Adorini
mesh_terms: D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D000949:Histocompatibility Antigens Class II; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007167:Immunotherapy / Q000379:methods*; D010455:Peptides / Q000276:immunology; D011506:Proteins / Q000276:immunology; D011948:Receptors, Antigen, T-Cell; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000949:Histocompatibility Antigens Class II; D010455:Peptides; D011506:Proteins; D011948:Receptors, Antigen, T-Cell